Aggarwal, R. R., Vuky, J., VanderWeele, D., Rettig, M., Heath, E. I., Quigley, D., Huang, J., Chumber, A., Cheung, A., Foye, A., Leung, S., Abbey, J., Dorr, A., Nasoff, M., Hunter, J., Wang, S., Flavell, R. R., Fong, L., Liu, B., Small, E. J. (2025). Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer. Journal of Clinical Oncology. https://doi.org/10.1200/jco-24-01989